Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety

Archiv der Pharmazie

Volumn 341, Issue 1, 2008, Pages 42-48

  Emami, Saeed ^a   Foroumadi, Alireza ^b   Faramarzi, Mohammad A ^b   Samadi, Nasrin ^b  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibacterial activity; Coumarin; Quinolones; Synthesis

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; ENOXACIN; N [2 (COUMARIN 3 YL) 2 OXOETHYL]CIPROFLOXACIN DERIVATIVE; N [2 (COUMATIN 3 YL)ETHYL]PIPERAZINYL QUINOLONE DERIVATIVE; NORFLOXACIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; COUMARINS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; QUINOLONES; SPECTROPHOTOMETRY, INFRARED; STAPHYLOCOCCAL INFECTIONS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 38949088221     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200700090     Document Type: Article

References (25)

1. K. Coleman, Drug Discov. Today, Therapeutic Strategies 2004, 1, 455-460.
2. P. Ball, J. Antimicrob. Chemother. 2000, 46, 17-24.
3. S. Emami, A. Shafiee, A. Foroumadi, Mini Rev. Med. Chem. 2006, 6, 375-386.
4. J. Fung-Tomc, B. Minassian, B. Kolek, T. Washo, et al., J. Antimicrob. Chemother. 2000, 45, 437-446.
5. F. Garcia-Garrote, E. Cercenado, J. Martin-Pedroviejo, O. Cuevas, E. Bouza, J. Antimicrob. Chemother. 2001, 47, 681-684.
6. J. H. Kim, J. A. Kang, Y. G. Kim, J. W. Kim, et al., Antimicrob. Agents Chemother. 1997, 41, 2209-2213.
7. J. Roca, Trends Biochem. Sci. 1995, 20, 156-160.
8. K. Drlica, X. Zhao, Microbiol. Mol. Biol. Rev. 1997, 61, 377-392.
9. L. Ferrero, B. Cameron, J. Crouzet, Antimicrob. Agents Chemother. 1995, 39, 1554-1558.
10. L. Ferrero, B. Cameron, B. Manse, D. Lagneaux, et al., Mol. Microbiol. 1994, 13, 641-653.
11. A. Maxwell, Mol. Microbiol. 1993, 9, 681-689.
12. B. Musicki, A.-M. Periers, P. Laurin, D. Ferroud, et al., Bioorg. Med. Chem. Lett. 2000, 10, 1695-1699.
13. L. Schio, F. Chatreaux, V. Loyau, M. Murer, et al., Bioorg. Med. Chem. Lett. 2001, 11, 1461-1464.
14. Q. Wang, E. Lucien, A. Hashimoto, G. C. Pais, et al., J. Med. Chem. 2007, 50, 199-210.
15. F. van Bambeke, J.-M. Michot, J. Van Eldere, P. M. Tulkens, Clin. Microbiol. Infec. 2005, 11, 256-280.
16. G. S. Tillotson, J. Med. Microbiol. 1996, 44, 320-324.
17. Y.-L. Chen, K.-C. Fang, J.-Y. Sheu, S.-L. Hsu, C.-C. Tzeng, J. Med. Chem. 2001, 44, 2374-2377.
18. A. Foroumadi, S. Emami, M. Mehni, M. H. Moshafi, A. Shafiee, Bioorg. Med. Chem. Lett. 2005, 15, 4536-4539.
19. A. Foroumadi, M. Oboudiat, S. Emami, A. Karimollah, et al., Bioorg. Med. Chem. 2006, 14, 3421-3427.
20. A. Foroumadi, S. Ghodsi, S. Emami, S. Najjari, et al., Bioorg. Med. Chem. Lett. 2006, 16, 3499-3503.
21. th International Conference of ISCB on Drug Discovery: perspectives and challenges, Feb 24-25, 2006, pp. 30-31, Central Drug Research Institute, Lucknow, India.
22. C. F. Koelsch, J. Am. Chem. Soc. 1950, 72, 2993-2995.
23. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clinical Microbiology and Infection, Eucast Definitive Document E. Def 3.1, 2000, 6, 509-515.
24. L. L. Shen, W. E. Kohlbrenner, D. Weigl, J. Baranowski, J. Biol. Chem. 1989, 264, 2973-2978.
25. L. L. Shen, J. Baranowski, A. G. Pernet, Biochemistry 1989, 28, 3879-3885.